Bio-Rad Laboratories (BIO) Net Margin (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Net Margin data on file, last reported at 89.02% in Q1 2026.

• On a quarterly basis, Net Margin fell 9995.0% year-over-year to 89.02% in Q1 2026; TTM through Mar 2026 was 6.52%, a 9168.0% increase from a year earlier, with the FY2025 full-year figure at 29.42%, up 10127.0% from the prior year.
• Net Margin for Q1 2026 stood at 89.02%, down from 103.87% in the prior quarter.
• Over the last five years, Net Margin for BIO reached as high as 113.35% in Q4 2022 and fell as low as 480.98% in Q1 2022.
• Historically, Net Margin has averaged 51.68% across 5 years, with a median of 10.19% in 2023.
• Across the five-year window, Net Margin tumbled 61546 bps in 2022 and surged 49117 bps in 2023, its largest moves.
• Year by year, Net Margin stood at 113.35% in 2022, then tumbled by 55 bps to 51.34% in 2023, then slumped by 309 bps to 107.24% in 2024, then jumped by 197 bps to 103.87% in 2025, then sank by 186 bps to 89.02% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 89.02% in Q1 2026, 103.87% in Q4 2025, and 52.36% in Q3 2025.